163 related articles for article (PubMed ID: 14606621)
21. In vitro susceptibility and resistance phenotypes in contemporary Citrobacter isolates in a University Hospital in Crete, Greece.
Maraki S; Vardakas KZ; Mavromanolaki VE; Kyriakidou M; Spais G; Kofteridis DP; Samonis G; Falagas ME
Infect Dis (Lond); 2017 Jul; 49(7):532-539. PubMed ID: 28276281
[TBL] [Abstract][Full Text] [Related]
22. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
[TBL] [Abstract][Full Text] [Related]
23. [Spondylitis due to Citrobacter diversus. Case report and review of Citrobacter diversus infections].
Müllner GF; Keller H
Schweiz Med Wochenschr; 1992 Aug; 122(31-32):1173-7. PubMed ID: 1496345
[TBL] [Abstract][Full Text] [Related]
24. Citrobacter braakii Bacteremia: Case Report and Review of the Literature.
Oyeka M; Antony S
Infect Disord Drug Targets; 2017; 17(1):59-63. PubMed ID: 27658860
[TBL] [Abstract][Full Text] [Related]
25. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
[TBL] [Abstract][Full Text] [Related]
26. Citrobacter infections in a general hospital: characteristics and outcomes.
Samonis G; Karageorgopoulos DE; Kofteridis DP; Matthaiou DK; Sidiropoulou V; Maraki S; Falagas ME
Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):61-8. PubMed ID: 18682995
[TBL] [Abstract][Full Text] [Related]
27. Edwardsiella tarda Bacteremia, Okayama, Japan, 2005-2016.
Kamiyama S; Kuriyama A; Hashimoto T
Emerg Infect Dis; 2019 Oct; 25(10):1817-23. PubMed ID: 31539320
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
[TBL] [Abstract][Full Text] [Related]
29. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
Ye Y; Li JB; Ye DQ; Jiang ZJ
Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
[TBL] [Abstract][Full Text] [Related]
30. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
[TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations and prognostic factors of Morganella morganii bacteremia.
Lin TY; Chan MC; Yang YS; Lee Y; Yeh KM; Lin JC; Chang FY
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):231-6. PubMed ID: 25107625
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility of Citrobacter species to various antimicrobial agents.
Samonis G; Ho DH; Gooch GF; Rolston KV; Bodey GP
Antimicrob Agents Chemother; 1987 May; 31(5):829-30. PubMed ID: 3606084
[TBL] [Abstract][Full Text] [Related]
33. Enterobacter bacteremia.
Gupta N; Aparna ; Choudhary U; Garg N; Arora DR
J Assoc Physicians India; 2003 Jul; 51():669-72. PubMed ID: 14621034
[TBL] [Abstract][Full Text] [Related]
34. Fusobacterium bacteremia: clinical significance and outcomes.
Su CP; Huang PY; Yang CC; Lee MH
J Microbiol Immunol Infect; 2009 Aug; 42(4):336-42. PubMed ID: 19949758
[TBL] [Abstract][Full Text] [Related]
35. Circulation of
Venditti C; Fortini D; Villa L; Vulcano A; D'Arezzo S; Capone A; Petrosillo N; Nisii C; Carattoli A; Di Caro A
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559268
[TBL] [Abstract][Full Text] [Related]
36. Two chromosomally located qnrB variants, qnrB6 and the new qnrB16, in Citrobacter spp. isolates causing bacteraemia.
Sanchez-Cespedes J; Marti S; Soto SM; Alba V; Melción C; Almela M; Marco F; Vila J
Clin Microbiol Infect; 2009 Dec; 15(12):1132-8. PubMed ID: 19392890
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia.
Lee IK; Liu JW
J Microbiol Immunol Infect; 2006 Aug; 39(4):328-34. PubMed ID: 16926980
[TBL] [Abstract][Full Text] [Related]
38. Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance.
Ellabib MS; Ordonez A; Ramali A; Walli A; Benayad T; Shebrlo H
Saudi Med J; 2004 Dec; 25(12):1951-6. PubMed ID: 15711674
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia.
Menashe G; Borer A; Yagupsky P; Peled N; Gilad J; Fraser D; Riesenberg K; Schlaeffer F
Scand J Infect Dis; 2001; 33(3):188-93. PubMed ID: 11303808
[TBL] [Abstract][Full Text] [Related]
40. Citrobacter diversus brain abscess: case reports and molecular epidemiology.
Morgan MG; Stuart C; Leanord AT; Enright M; Cole GF
J Med Microbiol; 1992 Apr; 36(4):273-8. PubMed ID: 1560449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
